Forecast: Value Added of Chemical and Pharmaceutical Products in the Netherlands

The value added of chemical and pharmaceutical products in the Netherlands has shown significant growth from 2013 to 2023, with a notable year-on-year increase reaching 15.96 billion euros in 2023. Over the last two years, the sector saw modest annual growth rates of 1.97% in 2022 and 1.9% in 2023, indicating steady but slowed expansion. The compound annual growth rate (CAGR) over the last five years was 1.75%, highlighting consistent performance. Future forecasts suggest a continued gradual increase, with a projected 1.33% CAGR over the next five years, culminating in a value added of 17.35 billion euros by 2028.

Trends to watch for include:

- Innovations in drug development and delivery

- Advancements in sustainable and green chemistry

- Regulatory changes impacting the pharmaceutical sector

- Potential economic impacts from global supply chain shifts